Mektovi
Jump to navigation
Jump to search
| Mektovi | |
|---|---|
| Term | Mektovi |
| Short definition | Mektovi - (pronounced) (mek-TOH-vee) drug used with encorafenib to treat melanoma that has spread or cannot be surgically removed and has a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Mektovi - (pronounced) (mek-TOH-vee) drug used with encorafenib to treat melanoma that has spread or cannot be surgically removed and has a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Mektovi blocks proteins called MEK1 and MEK2, which can help prevent cancer cells from growing. It's a kind of kinase inhibitor. Also called binimetinib
External links
- Medical encyclopedia article on Mektovi
- Wikipedia's article - Mektovi
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski